Cargando…

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score

Detalles Bibliográficos
Autores principales: Schaule, Jana, Kroeze, Stephanie G. C., Blanck, Oliver, Stera, Susanne, Kahl, Klaus H., Roeder, Falk, Combs, Stephanie E., Kaul, David, Claes, An, Schymalla, Markus M., Adebahr, Sonja, Eckert, Franziska, Lohaus, Fabian, Abbasi-Senger, Nasrin, Henke, Guido, Szuecs, Marcella, Geier, Michael, Sundahl, Nora, Buergy, Daniel, Dummer, Reinhard, Guckenberger, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734768/
https://www.ncbi.nlm.nih.gov/pubmed/33317582
http://dx.doi.org/10.1186/s13014-020-01708-y
_version_ 1783622531549233152
author Schaule, Jana
Kroeze, Stephanie G. C.
Blanck, Oliver
Stera, Susanne
Kahl, Klaus H.
Roeder, Falk
Combs, Stephanie E.
Kaul, David
Claes, An
Schymalla, Markus M.
Adebahr, Sonja
Eckert, Franziska
Lohaus, Fabian
Abbasi-Senger, Nasrin
Henke, Guido
Szuecs, Marcella
Geier, Michael
Sundahl, Nora
Buergy, Daniel
Dummer, Reinhard
Guckenberger, Matthias
author_facet Schaule, Jana
Kroeze, Stephanie G. C.
Blanck, Oliver
Stera, Susanne
Kahl, Klaus H.
Roeder, Falk
Combs, Stephanie E.
Kaul, David
Claes, An
Schymalla, Markus M.
Adebahr, Sonja
Eckert, Franziska
Lohaus, Fabian
Abbasi-Senger, Nasrin
Henke, Guido
Szuecs, Marcella
Geier, Michael
Sundahl, Nora
Buergy, Daniel
Dummer, Reinhard
Guckenberger, Matthias
author_sort Schaule, Jana
collection PubMed
description
format Online
Article
Text
id pubmed-7734768
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77347682020-12-15 Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score Schaule, Jana Kroeze, Stephanie G. C. Blanck, Oliver Stera, Susanne Kahl, Klaus H. Roeder, Falk Combs, Stephanie E. Kaul, David Claes, An Schymalla, Markus M. Adebahr, Sonja Eckert, Franziska Lohaus, Fabian Abbasi-Senger, Nasrin Henke, Guido Szuecs, Marcella Geier, Michael Sundahl, Nora Buergy, Daniel Dummer, Reinhard Guckenberger, Matthias Radiat Oncol Correction BioMed Central 2020-12-14 /pmc/articles/PMC7734768/ /pubmed/33317582 http://dx.doi.org/10.1186/s13014-020-01708-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Schaule, Jana
Kroeze, Stephanie G. C.
Blanck, Oliver
Stera, Susanne
Kahl, Klaus H.
Roeder, Falk
Combs, Stephanie E.
Kaul, David
Claes, An
Schymalla, Markus M.
Adebahr, Sonja
Eckert, Franziska
Lohaus, Fabian
Abbasi-Senger, Nasrin
Henke, Guido
Szuecs, Marcella
Geier, Michael
Sundahl, Nora
Buergy, Daniel
Dummer, Reinhard
Guckenberger, Matthias
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title_full Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title_fullStr Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title_full_unstemmed Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title_short Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
title_sort correction to: predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: melanoma brain metastases prognostic score
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734768/
https://www.ncbi.nlm.nih.gov/pubmed/33317582
http://dx.doi.org/10.1186/s13014-020-01708-y
work_keys_str_mv AT schaulejana correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT kroezestephaniegc correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT blanckoliver correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT sterasusanne correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT kahlklaush correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT roederfalk correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT combsstephaniee correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT kauldavid correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT claesan correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT schymallamarkusm correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT adebahrsonja correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT eckertfranziska correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT lohausfabian correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT abbasisengernasrin correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT henkeguido correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT szuecsmarcella correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT geiermichael correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT sundahlnora correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT buergydaniel correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT dummerreinhard correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore
AT guckenbergermatthias correctiontopredictingsurvivalinmelanomapatientstreatedwithconcurrenttargetedorimmunotherapyandstereotacticradiotherapymelanomabrainmetastasesprognosticscore